Clinical Trial Update: A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating ENERGI-F703 GEL for diabetic foot ulcers, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer

Drugs mentioned

• ENERGI-F703 GEL

Snippet

Sponsor: Energenesis Biomedical Co., Ltd. | Conditions: Diabetic Foot Ulcer, Foot Ulcer | Phase 3 | Status: RECRUITING